Escola Paulista de Medicina
Postgraduate in Clinical Endocrinology
Rubens Marcella-Neto a, João R. de Sá b, Cláudio S. Melaragno a, Adriano M. Gonzalez [ ... ]
Artigos CientificosCarolina Aguiar Moreira1,2,3
Carlos Eduardo dos S. Ferreira4,5,6
Miguel Madeira1,7
Barbara Campolina Carvalho [ ... ]
Objective: As Selumetinib is a MEK1/2 inhibitor that has gained interest as an anti-tumor agent, [ ... ]
© 2013 - 2019 Universidade Federal de São Paulo - Unifesp
Rua Estado de Israel, 639 - Vila Clementino - São Paulo/SP - 04022-001 • 5089-9200 Ramal 2416